Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Pediatr Infect Dis J ; 41(11): e478-e480, 2022 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-36102698

RESUMO

Actinomycosis of the middle ear is a rare infectious disease, characterized by a slowly progressive clinical course. We report the case of a 9-year-old girl with recurrent otitis media, who presented with clinical signs of a cholesteatoma. She underwent tympanoplasty and ossiculoplasty. After surgery, actinomycosis was diagnosed histologically. We also provide a review of 16 published pediatric cases.


Assuntos
Actinomicose , Otite Média , Actinomicose/diagnóstico , Criança , Orelha Média/cirurgia , Feminino , Humanos , Otite Média/diagnóstico , Otite Média/cirurgia , Recidiva , Timpanoplastia
2.
Pediatr Int ; 64(1): e15294, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36134651

RESUMO

BACKGROUND: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is an autoinflammatory disease occurring in children. Although PFAPA is the most common periodic fever syndrome found in children, there are only a few studies defining the clinical characteristics and the efficacy of treatment strategies among Japanese children. This study aimed to clarify the demographic characteristics and clinical features of patients with PFAPA syndrome and to evaluate treatment efficacy. METHODS: We retrospectively reviewed the clinical features of children with PFAPA who visited Saitama Children's Medical Center between January and December 2019. We also evaluated treatment strategies and their efficacy; abortive treatment with corticosteroids, prophylaxis with cimetidine or colchicine, and surgical management with tonsillectomy. RESULTS: A total of 100 Japanese children (61% male) with PFAPA were included. Median age of onset was 3 years, median duration of fever episodes was 5 days, and median interval between episodes was 4 weeks. The symptoms (frequencies) were pharyngitis (89%), exudate on tonsils (71%), cervical adenitis (50%), and aphthous stomatitis (49%). Approximately 37% of patients took prednisolone for aborting fever attacks, showing a 100% response; 93% were treated with cimetidine, showing an 79.6% response, and 18% were treated with colchicine, showing a 66.7% response. Only one patient underwent tonsillectomy. CONCLUSIONS: Among Japanese children with PFAPA, 28% of them were ≥5 years with a male predominance. Pharyngitis is the most frequent symptom associated with fever. Cimetidine is suitable for initial therapy because of its safety and efficacy.


Assuntos
Linfadenite , Linfadenopatia , Faringite , Estomatite Aftosa , Tonsilectomia , Criança , Cimetidina/uso terapêutico , Colchicina/uso terapêutico , Feminino , Febre/complicações , Febre/etiologia , Humanos , Recém-Nascido , Japão/epidemiologia , Linfadenite/diagnóstico , Linfadenite/epidemiologia , Linfadenite/terapia , Linfadenopatia/complicações , Masculino , Faringite/complicações , Faringite/diagnóstico , Faringite/terapia , Prednisolona , Estudos Retrospectivos , Estomatite Aftosa/diagnóstico , Estomatite Aftosa/epidemiologia , Estomatite Aftosa/terapia , Síndrome , Resultado do Tratamento
3.
BMC Pediatr ; 21(1): 265, 2021 06 05.
Artigo em Inglês | MEDLINE | ID: mdl-34090356

RESUMO

BACKGROUND: Spontaneous infection of preexisting solitary renal cysts has been documented in adults but is extremely rare in children. To date, no cases of simple renal cysts infected with Streptococcus pneumoniae have been described. Recently, reports have described the diagnosis of bacterial infection using the 16 S rRNA gene as well as the accompanying antimicrobial stewardship for microorganisms that are difficult to culture and for culture-negative cases after preceding antibacterial administration. CASE PRESENTATION: A four-year-old Japanese girl who had a pleuroperitoneal shunt inserted to drain a right pleural effusion due to occlusion of the hepatic portion of the inferior vena cava at three years old visited our hospital due to fever and respiratory discomfort. She was incidentally found to have a right simple renal cyst 10 months before admission. The patient was suspected to have pneumonitis or catheter-related blood stream infection on chest X-ray, which showed right-side pleural effusion. She was diagnosed with invasive pneumococcal infection, as Streptococcus pneumoniae was detected from blood culture on admission. Transient improvements in her symptoms and decreases in the white blood cell count and C-reactive protein level were observed after effective antibiotic administration, but her respiratory condition deteriorated. Enhanced CT showed right renal cyst enlargement and enhancement and thickening of the surrounding wall. Using the melting temperature (Tm) mapping method, S. pneumoniae was rapidly detected directly from pus 4.5 hours after drainage. The specimen culture was negative, but the extracted 16 S rDNA sequence revealed 100 % identity for S. pneumoniae from the same specimen the subsequent day. We successfully performed optimal treatment and reduced medical cost based on the positive Tm mapping method result. CONCLUSIONS: We report the first case of a S. pneumoniae-infected simple renal cyst. The drainage culture was negative, but the Tm mapping method rapidly detected S. pneumoniae directly from the drainage. The Tm mapping method may have great impacts on rapid diagnosis and effective antimicrobial stewardship.


Assuntos
Doenças Renais Císticas , Derrame Pleural , Infecções Pneumocócicas , Adulto , Criança , Pré-Escolar , Feminino , Humanos , Infecções Pneumocócicas/complicações , Infecções Pneumocócicas/diagnóstico , Infecções Pneumocócicas/tratamento farmacológico , Streptococcus pneumoniae/genética , Termografia
5.
Int J Infect Dis ; 100: 373-376, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32976992

RESUMO

The Bacillus Calmette-Guérin (BCG) vaccine is widely used worldwide. Intracranial manifestation as an adverse event of BCG is extremely rare. A previously healthy 16-month-old boy was referred to our hospital for eye contact difficulties and progressive gait disturbance lasting two months. He was inoculated with BCG at seven months of age. Brain magnetic resonance imaging (MRI) revealed hydrocephalus with widespread and disseminated enhancement lesions with thickening of the third ventricle floor, and brain tissue pathologically showed non-caseous granulomatous inflammation. Immunosuppressive therapies were initiated because of a provisional diagnosis of neurosarcoidosis. Three months later, a positive polymerase chain reaction (PCR) result for the Mycobacterium tuberculosis complex was obtained. Eventually, M. bovis (BCG Tokyo 172 strain) was identified in the cerebrospinal fluid (CSF) and shunt tube culture. The prolonged use of antituberculosis drugs and multiple shunt replacement surgeries were needed for recovery. There was no evidence of immunodeficiency. Unfortunately, he had severe neurological sequelae of bilateral blindness and neurodevelopmental delay. Our purpose in this report was to highlight the potential for intracranial manifestations of adverse reactions related to BCG vaccination. We propose that the CSF PCR assay of Mycobacterium tuberculosis (MTB) complex should be applied repeatedly in children suspected of intractable neurosarcoidosis, with a history of BCG vaccination.


Assuntos
Vacina BCG/efeitos adversos , Ventriculite Cerebral/microbiologia , Meningite/microbiologia , Mycobacterium bovis/imunologia , Vacina BCG/administração & dosagem , Encéfalo/diagnóstico por imagem , Encéfalo/microbiologia , Ventriculite Cerebral/diagnóstico por imagem , Ventriculite Cerebral/etiologia , Humanos , Lactente , Imageamento por Ressonância Magnética , Masculino , Meningite/diagnóstico por imagem , Meningite/etiologia , Mycobacterium bovis/genética , Mycobacterium bovis/isolamento & purificação , Vacinação/efeitos adversos
7.
Glob Pediatr Health ; 4: 2333794X17736700, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29085866

RESUMO

We studied 3 patients with systemic lupus erythematosus (SLE) who developed thyroid cancer (TC). Potential risk factors for TC development was explored. Fifty-three patients with a clinical diagnosis of rheumatic diseases including SLE at our hospital between July 2014 and December 2014 were enrolled. Demographic, clinical, and laboratory findings were retrospectively compared between TC-positive and TC-negative patients. Among rheumatic diseases, lymphadenopathy/splenomegaly at treatment commencement, and lymphadenopathy/splenomegaly, painless ulcer (oral, nasal, or mucosal), and weight loss during the entire study period were precipitating factors. Lower current values of hemoglobin and methylprednisolone pulse therapy favored TC development. In 29 SLE patients, lymphadenopathy/splenomegaly at treatment commencement, lymphadenopathy/splenomegaly and weight loss during the entire study period, urinary granular casts at treatment commencement, and a lower current value of hemoglobin predisposed patients to TC. Several risk factors of TC are present in pediatric SLE. Patients with SLE should be investigated vigorously for TC with ultrasound.

8.
Pediatr Res ; 81(4): 593-600, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27997528

RESUMO

BACKGROUND: Kawasaki disease is a common systemic vasculitis that leads to coronary artery lesions. Besides its antihypertensive effects, losartan can modulate inflammation in cardiovascular disease. We examined whether losartan can attenuate coronary inflammation in a murine model of Kawasaki disease. METHODS AND RESULTS: Five-wk-old C57/BL6J male mice were intraperitoneally injected with Lactobacillus casei cell wall extract to induce coronary inflammation and divided into four groups: placebo, intravenous immunoglobulin (IVIG), losartan, and IVIG+losartan. After 2 wk, mice were harvested. The coronary perivasculitis was significantly attenuated by losartan but not by IVIG alone, and further dramatic attenuation by IVIG+losartan was observed. The frequency of Lactobacillus casei cell wall extract-induced myocarditis (80%) was markedly lowered by losartan (22%) and IVIG+losartan (0%). Furthermore, interleukin (IL)-6 mRNA was markedly attenuated by IVIG+losartan. Serum levels of IL-6, TNF-α, MCP-1, and IL-10 after Lactobacillus casei cell wall extract injection were slightly decreased by IVIG or losartan. Moreover, IL-1ß, IL-10, and MCP-1 levels were significantly decreased by IVIG+losartan. CONCLUSION: The addition of losartan to IVIG strongly attenuated the severity of coronary perivasculitis and the incidence of myocarditis, along with suppressing systemic/local cytokines as well as the activated macrophage infiltration. Therefore, losartan may be a potentially useful additive drug for the acute phase of Kawasaki disease to minimize coronary artery lesions.


Assuntos
Antiarrítmicos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Losartan/uso terapêutico , Síndrome de Linfonodos Mucocutâneos/tratamento farmacológico , Vasculite/tratamento farmacológico , Animais , Parede Celular , Quimiocina CCL2/sangue , Modelos Animais de Doenças , Imuno-Histoquímica , Inflamação , Infusões Intravenosas , Interleucina-10/sangue , Interleucina-1beta/sangue , Interleucina-6/sangue , Lacticaseibacillus casei , Macrófagos/citologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Fator de Necrose Tumoral alfa/sangue
9.
Inflammation ; 35(3): 952-8, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22012196

RESUMO

Although there is ample evidence that Kawasaki disease (KD) is associated with vascular inflammation, few studies have addressed the influence of oxidative stress. The goal of this study was to determine whether oxidative stress contributes to inflammation during KD, and also whether corticosteroid therapy can reduce oxidative stress. Serum reduced glutathione (sGSH) and serum thioredoxin (sTRX) were measured during KD to evaluate the phase-dependent change in the redox state in KD. Additionally, the efficacy of the therapies to reduce oxidative stress was assessed. The sGSH level significantly decreased post-intravenous immunoglobulin (IVIG). The sGSH level significantly increased during the convalescent phase. The sTRX level was significantly lower during the convalescent phase than that during the pre- and the post-IVIG. There was no difference in the sGSH and sTRX changes between the IVIG therapy and the IVIG + prednisolone (PSL) therapy, except for the convalescent phase in sTRX. Systemic inflammation in KD induces changes in the redox state, whereas the IVIG + PSL therapy did not show any remarkable change on oxidative stress in comparison to the IVIG therapy. Therapeutic intervention against oxidative stress might therefore be beneficial as adjunctive therapies for KD.


Assuntos
Anti-Inflamatórios/uso terapêutico , Imunoglobulinas Intravenosas/uso terapêutico , Inflamação/terapia , Síndrome de Linfonodos Mucocutâneos/metabolismo , Síndrome de Linfonodos Mucocutâneos/terapia , Estresse Oxidativo/efeitos dos fármacos , Prednisolona/uso terapêutico , Pré-Escolar , Terapia Combinada , Feminino , Glutationa/sangue , Humanos , Lactente , Masculino , Síndrome de Linfonodos Mucocutâneos/tratamento farmacológico , Oxirredução/efeitos dos fármacos , Tiorredoxinas/sangue , Resultado do Tratamento
10.
Tokai J Exp Clin Med ; 29(1): 1-5, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15449805

RESUMO

In pediatric practice, the application of fiberoptic bronchoscopy (FBS) has been limited to infants and children, primarily because the caliber of the available fiberscopes was too large for application to small babies including newborns. Recently, fiberscopes with thinner calibers were generated, prompting application of FBS to newborn patients. In the recent five years, we have utilized narrow-caliber FBS at the Neonatal Intensive Care Unit of the Tokai University Hospital. Through 21 FBS applications on newborn patients for various indications, we conclude that given careful monitoring of the patient's systemic conditions and management of ventilation, FBS can be safely applied on small babies including newborn patients and facilitate treatment of the airway problems.


Assuntos
Broncoscopia/estatística & dados numéricos , Tecnologia de Fibra Óptica/instrumentação , Obstrução das Vias Respiratórias/diagnóstico , Obstrução das Vias Respiratórias/patologia , Broncoscópios , Humanos , Lactente , Recém-Nascido , Unidades de Terapia Intensiva Neonatal , Japão , Monitorização Fisiológica , Doenças Respiratórias/diagnóstico , Doenças Respiratórias/patologia
11.
Arterioscler Thromb Vasc Biol ; 24(11): 2143-8, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15374850

RESUMO

OBJECTIVE: We evaluated the role of angiotensin II (AII) in a marrow-derived macrophage-driven model of atherosclerosis. METHODS AND RESULTS: Eight-week-old C57BL/6 wild-type mice were reconstituted with bone marrow harvested from apolipoprotein E-deficient (apoE-/---> apoE+/+) or wild-type for apoE gene (apoE+/+--> apoE+/+) mice. At 20 weeks, mice were exposed to either AII (1000 ng/kg per minute subcutaneously) or saline for 2 weeks. Animals did not differ in body weight, blood pressure, cholesterol/triglycerides, or peripheral blood monocyte counts. ApoE-/---> apoE+/+ mice exposed to AII had 3-fold greater atherosclerotic area than saline-treated apoE-/---> apoE+/+ mice. By contrast, AII did not affect atherosclerosis in apoE+/+--> apoE+/+ mice. Macrophage-positive areas were increased by AII in mice reconstituted with either apoE-deficient or apoE-competent marrow. AII also significantly increased fragmentation of elastin laminae in both apoE-/---> apoE+/+ and apoE+/+--> apoE+/+ mice. In vitro, AII caused greater increase in monocyte chemoattractant protein-1-stimulated migration of macrophages harvested from AII-infused versus saline-infused mice. CONCLUSIONS: The current studies reveal that AII has both initiating and sustaining proatherogenic effects. By promoting macrophage migration into the vascular intima, AII is pivotal in initiating atherosclerosis; by promoting elastin breaks, a novel mechanism implicated in migration and proliferation of smooth muscle cells, AII may be pivotal in subsequent development and expansion of atherosclerotic lesion.


Assuntos
Angiotensina II/farmacologia , Arteriosclerose/metabolismo , Arteriosclerose/patologia , Macrófagos/metabolismo , Angiotensina II/administração & dosagem , Animais , Apolipoproteínas E/deficiência , Apolipoproteínas E/fisiologia , Transplante de Medula Óssea/métodos , Movimento Celular/efeitos dos fármacos , Colesterol/metabolismo , Modelos Animais de Doenças , Feminino , Bombas de Infusão Implantáveis , Macrófagos Peritoneais/metabolismo , Camundongos , Camundongos Endogâmicos C57BL
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA